الاثنين، 30 يونيو 2014

CASL - A Quick Guide and the Death of Single Opt-In


CASL – A Quick Guide and the Death of Single Opt-In

By Phil Hollows

CASL – the Canadian Anti-Spam Law – takes effect tomorrow, July 1st, 2014.

There’s a lot of fluff and BS floating around, and since there is no enforcement to date, there’s no real guidance from the authorities nor case law to follow. As far as email marketing is concerned, though, what CASL enforces is full-contact permission marketing, with an “implied consent” grace for where there is an existing communications relationship. OK, so what does that mean in practice?

CASL In a Nutshell

As we see CASL, it’s like this (remember we’re not lawyers, but we are passionate about best practice):

  • If your emails are all acquired by dual opt-in, you’re GOOD! Carry on!
  • If you’ve been mailing the list for some time, you have implied consent, you don’t need to reacquire permission for existing subscribers.
  • If you are a subscriber to an existing list, you don’t have to email the list owner or their email service to demand permission. If you want it, you’re OK.

Where does it get murky? Well, all those shady practices which you ought not to be doing anyway just got a whole lot riskier.

  • Do not buy or rent lists. Ever. This was true before now, but now it’s EXTRA true, because million dollar fines.
  • Don’t use third party services to acquire email addresses.
  • Email appending looks really risky going forward, don’t do it. h/t copyblogger for that one.
  • Don’t add someone to your list who: Gave you a business card / is a LinkedIn contact / was an attendee at a conference you sponsored.
  • I’d be really uncomfortable if you run promotions or competitions, such as on Facebook, where you acquire unvalidated email addresses.
  • Single opt-in? No. No. No.

CASL is the Death Of Single Opt-In

Why? Because there’s no proof of permission, that’s why, which is what CASL is all about. I’d argue that acquiring email addresses and mailing them via single opt in is now fundamentally illegal under CASL and a massive business risk. Without verification and confirmation of the would-be subscribers intent, you can’t say you have permission. You just have an email address. And so you fail the CASL sniff test. Period.

Single opt-in could even be used maliciously to add a third party Canadian email address to your list, with the purpose of having them sue you when you bulk mail them.

Likely? Eh (hehe, it is a Canadian law), probably not. Possible? Maybe.

I’ve heard publishers complain that they “lose” subscribers in dual opt-in because not everyone completes the process. That’s the whole point. Someone who puts their name into a form on your web site is NOT a subscriber until they confirm. Put another way, you want people who want to be on your list on your list, and you don’t want people who don’t want to be on your list on your list (read that a couple of times, it actually makes sense). Not everyone who starts the process completes it because they’re just not that into you. And that’s OK.

Single opt-in cannot provide the proof of permission that CASL demands.

CASL requires PROOF.

So: If you haven’t already, make sure you’re using dual opt-in. Stop shady email acquisition. Embrace best practice (it’s called “best” for a reason, people). And then, relax. You’re going to be fine.


 

Sponsor message
powered byad choices

Get These Great e-Books from FeedBlitz

Get the free FeedBurner Migration Guide e-book Buy List Building for Bloggers, proven email strategies to build your audience, increase engagement and grow your income. Find out how to make the most of FeedBlitz.

 


Sponsor message
powered byad choices



Email subscriptions powered by FeedBlitz, LLC, 365 Boston Post Rd, Suite 123, Sudbury, MA 01776, USA.

 

Bots Behaving Badly and your RSS Stats


Bots Behaving Badly and your RSS Stats

By Phil Hollows

Seems that a rogue bot (it shows up in your RSS metrics as “experibot_v”) has been busy this weekend, and has artificially inflated RSS subscriber tallies. So panic (or rejoice, depending on your mindset) not: It’s not real eyeballs and we’re fixing everyone’s metrics to eliminate it from your results.  I’ll update this post as when this task has been completed.


 

Sponsor message
powered byad choices

Get These Great e-Books from FeedBlitz

Get the free FeedBurner Migration Guide e-book Buy List Building for Bloggers, proven email strategies to build your audience, increase engagement and grow your income. Find out how to make the most of FeedBlitz.

 


Sponsor message
powered byad choices



Email subscriptions powered by FeedBlitz, LLC, 365 Boston Post Rd, Suite 123, Sudbury, MA 01776, USA.

 

ScienceDaily: Top News

ScienceDaily: Top News


Noninvasive brain control: New light-sensitive protein enables simpler, more powerful optogenetics

Posted: 29 Jun 2014 11:21 AM PDT

Engineers have now developed the first light-sensitive molecule that enables neurons to be silenced noninvasively, using a light source outside the skull. This noninvasive approach could pave the way to using optogenetics in human patients to treat epilepsy and other neurological disorders.

Emperor penguin in peril

Posted: 29 Jun 2014 11:20 AM PDT

Scientists studying Emperor penguin populations across Antarctica finds the iconic animals in danger of dramatic declines by the end of the century due to climate change. Their study finds the Emperor penguin 'fully deserving of endangered status due to climate change.'

ScienceDaily: Health & Medicine News

ScienceDaily: Health & Medicine News


Noninvasive brain control: New light-sensitive protein enables simpler, more powerful optogenetics

Posted: 29 Jun 2014 11:21 AM PDT

Engineers have now developed the first light-sensitive molecule that enables neurons to be silenced noninvasively, using a light source outside the skull. This noninvasive approach could pave the way to using optogenetics in human patients to treat epilepsy and other neurological disorders.

Ankle replacement becomes more common to relieve severe arthritis pain

Posted: 27 Jun 2014 06:27 PM PDT

Improvements in implant design have prompted more people with severe arthritis in their ankle to consider ankle replacement to relieve pain. The newest implant is considered by many to be an advance over previous models, designed to better reproduce the ankle's natural motion and last longer.

New routine testing for some non-hodgkin lymphomas recommended

Posted: 26 Jun 2014 10:20 AM PDT

Three subgroups of a single type of non-Hodgkin lymphoma that have markedly different survival rates have been discovered by researchers. These subgroups could not be differentiated by routine pathology but only with the aid of novel genetic tests, which the research team recommends giving to all patients with ALK-negative anaplastic large-cell lymphoma (ALCL).

Diabolical duo: Known breast cancer gene needs partner to initiate, spread tumors

Posted: 26 Jun 2014 09:18 AM PDT

A gene known as Metadherin promotes the survival of tumor-initiating cells via the interaction with a second molecule called SND1, researchers have found. The finding could suggest new treatment strategies. "This is one of the first examples of a gene playing crucial roles in both the early and late steps of breast cancer progression," said the senior corresponding author.